Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
What is Beximco Pharmaceuticals stock price today?▼
The current price of BXP.LSE is GBX42.5 GBX — it has increased by +6.25% in the past 24 hours. Watch Beximco Pharmaceuticals stock price performance more closely on the chart.
What is Beximco Pharmaceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Beximco Pharmaceuticals stocks are traded under the ticker BXP.LSE.
Is Beximco Pharmaceuticals stock price growing?▼
BXP.LSE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Beximco Pharmaceuticals has showed a +16.89% increase.
What is Beximco Pharmaceuticals market cap?▼
Today Beximco Pharmaceuticals has the market capitalization of 189.6M
What were Beximco Pharmaceuticals earnings last quarter?▼
BXP.LSE earnings for the last quarter are 2.87 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Beximco Pharmaceuticals revenue for the last year?▼
Beximco Pharmaceuticals revenue for the last year amounts to 7.02T GBX.
What is Beximco Pharmaceuticals net income for the last year?▼
BXP.LSE net income for the last year is 925.74B GBX.
Does Beximco Pharmaceuticals pay dividends?▼
Yes, BXP.LSE dividends are paid annual. The last dividend per share was 2.6 GBX. As of today, Dividend Yield (FWD)% is 6.12%.
How many employees does Beximco Pharmaceuticals have?▼
As of April 08, 2026, the company has 6,000 employees.
In which sector is Beximco Pharmaceuticals located?▼
Beximco Pharmaceuticals operates in the Health Care sector.
When did Beximco Pharmaceuticals complete a stock split?▼
The last stock split for Beximco Pharmaceuticals was on November 23, 2020 with a ratio of 1.1:1.
Where is Beximco Pharmaceuticals headquartered?▼
Beximco Pharmaceuticals is headquartered in Dhaka, GB.